<?xml version="1.0"?>
<rss version="2.0">
   <channel>
      <title>Gruppe IV by Gregor Benedikt Ottawa</title>
      <link>https://padlet.com/gregorottawa/dqvvna8hf5mqdk8a</link>
      <description>Phase II</description>
      <language>en-us</language>
      <pubDate>2022-09-01 07:25:01 UTC</pubDate>
      <lastBuildDate>2026-02-24 14:07:41 UTC</lastBuildDate>
      <webMaster>hello@padlet.com</webMaster>
      <image>
         <url>https://padlet.net/icons/png/0034-20e3.png</url>
      </image>
      <item>
         <title>Charakteristika:</title>
         <author>gregorottawa</author>
         <link>https://padlet.com/gregorottawa/dqvvna8hf5mqdk8a/wish/2278931319</link>
         <description><![CDATA[<p>-relative kurze Dauer (ca. 2 Jahre)</p><p>-enge Ein- und Ausschlusskriterien</p><p>-erstmalige Anwendung an Zielpopulation</p><p>-Bestimmung der Wirksamkeit in der Anwendung an Kranken</p>]]></description>
         <enclosure url="" />
         <pubDate>2022-09-01 07:25:01 UTC</pubDate>
         <guid>https://padlet.com/gregorottawa/dqvvna8hf5mqdk8a/wish/2278931319</guid>
      </item>
      <item>
         <title>Anzahl Probanden/Patienten:</title>
         <author>gregorottawa</author>
         <link>https://padlet.com/gregorottawa/dqvvna8hf5mqdk8a/wish/2278931320</link>
         <description><![CDATA[<p>100-300 Erkrankte</p>]]></description>
         <enclosure url="" />
         <pubDate>2022-09-01 07:25:01 UTC</pubDate>
         <guid>https://padlet.com/gregorottawa/dqvvna8hf5mqdk8a/wish/2278931320</guid>
      </item>
      <item>
         <title>Beobachtet wird...:</title>
         <author>gregorottawa</author>
         <link>https://padlet.com/gregorottawa/dqvvna8hf5mqdk8a/wish/2278931322</link>
         <description><![CDATA[<p>-Verträglichkeit</p><p>-Nebenwirkungen</p><p>-optimale Dosierung </p><p>-Wirksamkeit (ob sich der gewünschte therapeutische Effekt zeigt) </p>]]></description>
         <enclosure url="" />
         <pubDate>2022-09-01 07:25:01 UTC</pubDate>
         <guid>https://padlet.com/gregorottawa/dqvvna8hf5mqdk8a/wish/2278931322</guid>
      </item>
      <item>
         <title>Ziel(e):</title>
         <author>gregorottawa</author>
         <link>https://padlet.com/gregorottawa/dqvvna8hf5mqdk8a/wish/2278931323</link>
         <description><![CDATA[<p>-Optimale Dosierung und Therapiedauer</p>]]></description>
         <enclosure url="" />
         <pubDate>2022-09-01 07:25:01 UTC</pubDate>
         <guid>https://padlet.com/gregorottawa/dqvvna8hf5mqdk8a/wish/2278931323</guid>
      </item>
      <item>
         <title>Bemerkungen:</title>
         <author>gregorottawa</author>
         <link>https://padlet.com/gregorottawa/dqvvna8hf5mqdk8a/wish/2278931324</link>
         <description><![CDATA[<p>Entscheidung, ob die Entwicklung in Phase 3 fortgesetzt wird.</p>]]></description>
         <enclosure url="" />
         <pubDate>2022-09-01 07:25:01 UTC</pubDate>
         <guid>https://padlet.com/gregorottawa/dqvvna8hf5mqdk8a/wish/2278931324</guid>
      </item>
      <item>
         <title>Dauer:</title>
         <author></author>
         <link>https://padlet.com/gregorottawa/dqvvna8hf5mqdk8a/wish/2284496352</link>
         <description><![CDATA[<p>ca. 2 Jahre</p>]]></description>
         <enclosure url="" />
         <pubDate>2022-09-06 11:58:11 UTC</pubDate>
         <guid>https://padlet.com/gregorottawa/dqvvna8hf5mqdk8a/wish/2284496352</guid>
      </item>
      <item>
         <title>Definition</title>
         <author>gregorottawa</author>
         <link>https://padlet.com/gregorottawa/dqvvna8hf5mqdk8a/wish/3050913728</link>
         <description><![CDATA[<p>Proof of concept (Beweis der Behauptung)</p>]]></description>
         <enclosure url="" />
         <pubDate>2024-07-11 08:38:16 UTC</pubDate>
         <guid>https://padlet.com/gregorottawa/dqvvna8hf5mqdk8a/wish/3050913728</guid>
      </item>
      <item>
         <title></title>
         <author></author>
         <link>https://padlet.com/gregorottawa/dqvvna8hf5mqdk8a/wish/3800207746</link>
         <description><![CDATA[<p>Phase IIa Proof of concept (kleine Pilotgruppe; kommt die Substanz am Target an?)</p><p>Phase IIb Dose finding </p>]]></description>
         <enclosure url="" />
         <pubDate>2026-02-24 13:22:23 UTC</pubDate>
         <guid>https://padlet.com/gregorottawa/dqvvna8hf5mqdk8a/wish/3800207746</guid>
      </item>
   </channel>
</rss>
